VISA is required for B cell expression of TLR7

Area of Science:

• Immunology
• Molecular Biology
• Autoimmunity

Background:

• B cells are crucial in systemic lupus erythematosus (SLE) development, with TLR7 expression being a key factor.
• Type I IFN from plasmacytoid dendritic cells typically controls B cell TLR7 expression.

Purpose of the Study:

• To investigate the role of VISA (also known as MAVS, IPS-1, CardIf) in regulating B cell expression of TLR7 and CD23.
• To understand the impact of VISA deficiency on B cell function and activation markers in the context of autoimmunity.

Main Methods:

• Analysis of B cells from VISA(-/-) mice.
• Cell transfer experiments to assess B cell-intrinsic effects.
• Evaluation of TLR7 agonist-induced activation markers, proliferation, cytokine production, and NF-κB activation.

Main Results:

• VISA(-/-) B cells exhibit reduced TLR7 expression and impaired TLR7 agonist-induced responses, including activation, proliferation, and cytokine production.
• The observed effects of VISA deficiency are intrinsic to B cells.
• Genetic background influences the phenotype of VISA(-/-) mice regarding TLR7 and CD23 expression.

Conclusions:

• VISA plays an unexpected role in regulating B cell TLR7 expression, independent of type I IFN levels.
• VISA-mediated cytosolic RNA sensing is linked to autoimmunity, suggesting potential therapeutic targets for SLE.
• Further research is needed to explore the influence of genetic background on VISA-mediated immune responses.